• VITALITY WELLNESS
  • Vitamin Infusions
  • Appointments
  • Women's Health
  • Men's Health
  • Weight Loss
  • Lab Screening
  • Hair Regrowth
  • Medical Forms
  • Zepbound for Sleep Apnea
  • Skin Care
  • LOCATIONS
    • Tampa Florida Telehealth
    • Ortonville Mi Clinic
    • Las Vegas NV Telehealth
    • Phoenix AZ Telehealth
  • DETAILS
    • About Us
    • Patient Resources
    • FAQ
  • More
    • VITALITY WELLNESS
    • Vitamin Infusions
    • Appointments
    • Women's Health
    • Men's Health
    • Weight Loss
    • Lab Screening
    • Hair Regrowth
    • Medical Forms
    • Zepbound for Sleep Apnea
    • Skin Care
    • LOCATIONS
      • Tampa Florida Telehealth
      • Ortonville Mi Clinic
      • Las Vegas NV Telehealth
      • Phoenix AZ Telehealth
    • DETAILS
      • About Us
      • Patient Resources
      • FAQ
  • Sign In
  • Create Account

  • Bookings
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Bookings
  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • VITALITY WELLNESS
  • Vitamin Infusions
  • Appointments
  • Women's Health
  • Men's Health
  • Weight Loss
  • Lab Screening
  • Hair Regrowth
  • Medical Forms
  • Zepbound for Sleep Apnea
  • Skin Care
  • LOCATIONS
    • Tampa Florida Telehealth
    • Ortonville Mi Clinic
    • Las Vegas NV Telehealth
    • Phoenix AZ Telehealth
  • DETAILS
    • About Us
    • Patient Resources
    • FAQ

Account


  • Bookings
  • My Account
  • Sign out


  • Sign In
  • Bookings
  • My Account

Patient Resources

Chronic Health Resources

World Health Organization (WHO)

American Diabetes Association (ADA)

World Health Organization (WHO)

The WHO provides global information on noncommunicable diseases (NCDs), including cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases. Explore their data, reports, and prevention strategies: WHO NCDs.

https://www.who.int/health-topics/

Mayo Clinic

American Diabetes Association (ADA)

World Health Organization (WHO)

The Mayo Clinic offers comprehensive information on various diseases and conditions, including chronic illnesses. Their website covers symptoms, causes, risk factors, treatments, and lifestyle recommendations. 

https://www.mayoclinic.org/diseases-conditions

American Diabetes Association (ADA)

American Diabetes Association (ADA)

Nutrition.gov - Overweight and Obesity

The ADA is a leading organization for diabetes prevention, management, and cure. Their website provides information, resources, events, and ways to get involved in the fight against diabetes. 

https://diabetes.org

Nutrition.gov - Overweight and Obesity

Nutrition.gov - Overweight and Obesity

Nutrition.gov - Overweight and Obesity

Learn about overweight and obesity, including causes, treatment, prevention, and lifestyle changes. 

https://www.nutrition.gov

MedlinePlus - Obesity Section

Nutrition.gov - Overweight and Obesity

CDC Chronic Disease Information

MedlinePlus offers information on defining adult overweight and obesity, healthy weight management, and related topics. 

https://medlineplus.gov

CDC Chronic Disease Information

Nutrition.gov - Overweight and Obesity

CDC Chronic Disease Information

The Centers for Disease Control and Prevention (CDC) provides comprehensive information on chronic diseases, including prevention, management, and data. You can learn about the most common chronic conditions in America, risk factors, and how to prevent conditions like heart disease, diabetes, and cancer. 

https://www.cdc.gov

American Heart Association (AHA)

American Heart Association (AHA)

American Heart Association (AHA)

The AHA is a nonprofit organization dedicated to fighting heart disease and stroke.

https://www.heart.org

Specialty Providers

Find Your Specialist

Federally Qualified Health Center

Federally Qualified Health Center

https://www.zocdoc.com

Federally Qualified Health Center

Federally Qualified Health Center

Federally Qualified Health Center

https://findahealthcenter.hrsa.gov

Webmd Care

Federally Qualified Health Center

Webmd Care

https://doctor.webmd.com

Blood Work Explained

Includes:

  • CBC: Is a group of blood tests that measure the number and size of the different cells in your blood. A CBC measures: Red blood cells, which carry oxygen from your lungs to the rest of your body. White blood cells, which fight infections and other diseases.


Includes:

  • Kidney Function: This is an evaluation of how your kidneys are functioning. The kidneys’ job is to filter the blood. Medications that are filtered by the kidney can accumulate in the blood if kidney function is not normal. A blood urea nitrogen (BUN) test measures the amount of urea nitrogen in your blood and is an indicator of the kidney’s ability to function as a filter. Creatinine is a compound produced by the muscles in your body and, like urea nitrogen, is filtered out of the blood by the kidneys. Measuring both of these levels can give your provider an idea of how your kidneys are functioning. 
  • Liver tests: Show substances made by the liver. Abnormal results can indicate liver inflammation, fatty liver, or damage to the heart, bones, or muscles. It can also be from medications, liver injury due to substance like alcohol consumption or hepatitis. 


Includes:

  • Lipid Panel: Helps to determine risk factors for cardiovascular disease and stroke. High LDL cholesterol or “low density lipoproteins” sometimes called “bad cholesterol” can indicate greater cardiovascular risk. Low HDL cholesterol or “high density lipoproteins” sometimes called “good cholesterol” can be similarly concerning for higher cardiovascular risk. High values of cholesterol and triglycerides, similarly, have been shown to be associated with increased risk of cardiovascular disease. 


Includes:

  • Thyroid stimulating hormone (TSH): Your thyroid is an important gland that helps regulate metabolism. A high or low level could indicate metabolic dysfunction. 


Includes:

  • Hemoglobin A1c: A1c is a measure of the long-term (3 month) history of your body’s ability to manage blood glucose. Elevated A1c can indicate problems regulating blood sugar levels, which is important for good health. An A1c 5.7-6.4 is an indication of Pre-diabetes which can lead to type 2 diabetes if left untreated. A1c higher than 6.5 is considered Type-2 diabetes. 


Includes:

  • PSA: Protein produced by the prostate gland that can be measured in a blood test to screen for prostate cancer.  An elevated PSA level may indicate the presence of enlarged prostate which is normal with age or prostate cancer. Though other factors can also cause elevated levels including prostate infections. 


Weight Loss Medication Details

Description

Tirzepatide is a novel, dual receptor agonist that targets both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. Initially developed for the treatment of type 2 diabetes, it is marketed under the brand name Mounjarofor glycemic control and has shown significant promise for weight loss, where the brand name Zepbound is being used. Administered as a once-weekly subcutaneous injection, tirzepatide has been shown to improve glycemic parameters and induce substantial weight loss when combined with lifestyle changes.

Also Known As

  • Generic Name: Tirzepatide
  • Brand Names:
    • Mounjaro (for type 2 diabetes)
    • Zepbound (for weight management)

It is sometimes referred to as a "twincretin" because of its simultaneous action on both the GLP-1 and GIP receptors.

Avoid When

Certain populations should exercise caution or avoid tirzepatide:

  • Type 1 Diabetes: It is not indicated for individuals with type 1 diabetes.
  • History of Pancreatitis: A past history of pancreatitis may warrant caution given the drug’s effects on the pancreas.
  • Personal or Family History of Medullary Thyroid Carcinoma or MEN2: While not as prominently emphasized as with semaglutide, caution is generally advised with medications in this class.
  • Pregnancy and Breastfeeding: As with many medications targeting metabolic pathways, the safety in pregnancy, while not fully established, remains a concern.
  • Severe Gastrointestinal Disorders: Those with significant GI diseases or related complications should be evaluated before starting tirzepatide.

Side Effects

The side effects of tirzepatide are largely related to its gastrointestinal activity:

  • Nausea: Like other incretin-based therapies, nausea is common in the early stages.
  • Vomiting & Diarrhea: These are also observed, contributing to the overall GI distress some patients experience.
  • Injection Site Reactions: Some users report mild irritation or discomfort at the injection site.
  • Decreased Appetite: While often therapeutic, it can be pronounced enough to affect nutrition in sensitive individuals.

Clinical trial data have documented these adverse effects, which are generally transient and tend to diminish with continued treatment.

How It Works in My Body

Tirzepatide’s mode of action is twofold:

  • GLP-1 Receptor Activation: By mimicking the GLP-1 hormone, it enhances glucose-dependent insulin secretion, suppresses glucagon release, and slows gastric emptying, resulting in improved blood sugar control and increased satiety.
  • GIP Receptor Activation: Concurrently, its action on the GIP receptor also promotes insulin release and may play a role in energy homeostasis, further contributing to its weight-loss effects.

This dual mechanism not only helps regulate blood sugar levels after meals but also reduces appetite, making it effective for both glycemic control and weight management.

Research Results

Recent clinical studies have demonstrated robust results with tirzepatide. In trials:

  • Type 2 Diabetes Management: Participants using tirzepatide experienced significant improvements in glycemic control along with reductions in body weight.
  • Weight Loss Outcomes: In studies focusing on obesity, patients achieved substantial weight loss across various dosing regimens; for example, higher doses (around 15 mg weekly) have been associated with an average loss of approximately 23–24 kg over 72 weeks.

These outcomes have fueled both enthusiasm for its metabolic benefits and ongoing research into its long-term safety and effectiveness.

Additional Insights

  • Dosing Flexibility: Tirzepatide is available in various dosages, allowing for individualized titration based on patient tolerance and therapeutic goals.
  • Integrated Lifestyle Approach: As with many metabolic therapies, combining tirzepatide with dietary modifications and increased physical activity yields the best outcomes.
  • Future Potential: Its dual incretin mechanism provides a unique therapeutic option, making it a subject of continued study not only for diabetes and obesity but also in the context of other metabolic disorders.
  • Patient Monitoring: Regular follow-ups are essential to monitor side effects, adjust dosing, and ensure the overall safety of the regimen.


Description

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It was originally approved by the FDA in 2019 for the management of type 2 diabetes. Later, in June 2021, it gained approval under the brand name Wegovy for use as a weight-loss treatment. The drug works by mimicking the effects of the natural hormone GLP-1 to enhance insulin secretion, lower glucagon levels, and slow gastric emptying, thereby helping control blood sugar and appetite.

Also Known As

  • Generic Name: Semaglutide
  • Brand Names:
    • Ozempic (primarily for type 2 diabetes and cardiovascular risk reduction)
    • Wegovy (specifically for weight management)
    • Rybelsus (an oral tablet formulation for type 2 diabetes)

Each brand has specific FDA-approved indications, yet all rely on semaglutide’s core GLP-1 receptor agonist activity.

Avoid When

Certain conditions warrant caution or outright avoidance when considering semaglutide:

  • History of Thyroid C-cell tumors: Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
  • Pregnancy: It is not recommended during pregnancy due to potential risks to the developing fetus.
  • Breastfeeding: Use is advised against in breastfeeding women since safety data are limited.
  • Trying to conceive: Due precautions should be taken when planning a pregnancy.
  • History of Eating Disorders: Specifically, patients with a history of anorexia or bulimia should exercise caution, as the drug’s effects on appetite and gastric emptying might exacerbate these conditions.

Side Effects

Clinical experience and trials have identified a range of gastrointestinal and other side effects associated with semaglutide. Notably:

  • Nausea: Reported by approximately 44% of users.
  • Vomiting: Reported in about 25% of cases.
  • Diarrhea/GI Distress: Occurs in roughly 30% of patients.

These side effects are generally thought to result from its action on the gastrointestinal system, particularly its delaying effect on gastric emptying. While many patients experience mild to moderate symptoms, these percentages help set expectations for what might occur during treatment.

How It Works in My Body

Semaglutide’s mechanism centers on its role as a GLP-1 receptor agonist:

  • Elevated Insulin Secretion: In response to food intake, semaglutide enhances insulin release from the pancreas, but only when blood glucose levels are elevated.
  • Reduced Glucagon Secretion: By lowering glucagon levels, it prevents excessive glucose output by the liver.
  • Delayed Gastric Emptying: The slowed movement of food from the stomach to the intestine promotes a feeling of fullness, which helps in reducing appetite and often leads to gastrointestinal side effects such as nausea.

This combination of effects supports its use in both blood sugar management and weight loss strategies by mimicking natural hormonal responses to food intake.

Research Results

Numerous clinical studies have validated semaglutide’s efficacy. Research indicates that when used in conjunction with a reduced-calorie diet and increased physical activity, semaglutide significantly improves glycemic control in people with type 2 diabetes and can lead to meaningful weight reduction in individuals with obesity. The landmark trials that led to its FDA approvals have demonstrated that semaglutide not only results in better metabolic outcomes but also reduces the risks of major cardiovascular events in at-risk populations.

Additional Insights and Considerations

  • Formulation Flexibility: Semaglutide offers both injectable and oral formulations, catering to patient preferences and compliance needs.
  • Long-Term Impact: Ongoing studies are further exploring its benefits on kidney function and cardiovascular events, broadening its potential use in chronic conditions associated with type 2 diabetes.
  • Lifestyle Integration: As with most medications for metabolic conditions, semaglutide shows the best results when it becomes part of an overall treatment strategy that includes balanced nutrition and regular physical activity.

Understanding semaglutide’s dual role in treating type 2 diabetes and obesity prompts further discussion on integrating lifestyle modifications with pharmacotherapy.


Description

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that was initially approved for the management of type 2 diabetes in 2010 under the brand name Victoza. Its potential for weight loss was later recognized, leading to an FDA approval in 2014 for chronic weight management under the brand name Saxenda. By mimicking the naturally occurring GLP-1 hormone, liraglutide improves glucose-dependent insulin secretion, suppresses glucagon release, and slows gastric emptying—all of which lead to improved blood sugar control and reduced appetite.

Also Known As

  • Generic Name: Liraglutide
  • Brand Names:
    • Victoza: Primarily used for type 2 diabetes management.
    • Saxenda: Approved for chronic weight management in adults with obesity or overweight individuals with weight-related conditions.

Although both formulations contain liraglutide, the dosing regimens and approved indications differ between the two brands.

Avoid When

Liraglutide should be used with caution or avoided in certain situations:

  • Personal or Family History of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2): Liraglutide is contraindicated due to the potential risk of thyroid C-cell tumors.
  • Pregnancy and Breastfeeding: It is not recommended during pregnancy or while breastfeeding because of limited safety data.
  • Personal Sensitivity to the Ingredients: As with any medication, a known hypersensitivity to liraglutide or any of its components is a contraindication.

Side Effects

The most common side effects associated with liraglutide include:

  • Gastrointestinal Discomfort: Nausea, vomiting, diarrhea, and constipation are frequent, particularly when first starting treatment.
  • Injection Site Reactions: Some patients may experience minor irritation, redness, or discomfort at the injection site.
  • Potential Pancreatitis: Although rare, there is a noted risk of pancreatitis, and any symptoms suggestive of this condition should be promptly evaluated.

How It Works in My Body

Liraglutide exerts its effects by acting as a GLP-1 receptor agonist:

  • Enhanced Insulin Secretion: In the presence of elevated blood glucose, liraglutide promotes insulin release from the pancreas in a regulated, glucose-dependent manner.
  • Inhibition of Glucagon Secretion: It reduces glucagon levels, which in turn helps to lower blood sugar by decreasing hepatic glucose production.
  • Delayed Gastric Emptying: By slowing the rate at which the stomach empties, liraglutide prolongs the feeling of fullness, thereby reducing appetite and decreasing caloric intake.
  • Central Appetite Regulation: Liraglutide also interacts with receptors in the central nervous system, contributing to reduced cravings and improved satiety.

These combined actions facilitate both better glycemic control and a reduction in body weight when used alongside diet and exercise.

Research Results

Clinical studies have consistently demonstrated that liraglutide is effective in both improving glycemic control and inducing weight loss:

  • Weight Reduction: In patients using Saxenda for weight management, research shows that a 5%–10% reduction in body weight over approximately 56 weeks can be achieved when the medication is combined with a reduced-calorie diet and increased physical activity.
  • Glycemic Control: For those with type 2 diabetes using Victoza, improvements in blood sugar control have been significant, with additional benefits noted in cardiovascular risk reduction.
  • Long-Term Outcomes: The benefits of liraglutide have been observed over extended treatment periods, with consistent results in weight loss and improved metabolic markers, making it a valuable option in the ongoing management of obesity and type 2 diabetes.

Additional Insights

  • Formulation and Dosing: The daily injection format of liraglutide offers a balance between efficacy and ease of use. The dosing differs between Victoza and Saxenda to meet the needs of blood sugar control versus weight loss, respectively.
  • Lifestyle Integration: As with most metabolic therapies, the optimal results with liraglutide are seen when it is integrated into a comprehensive lifestyle modification plan that includes dietary changes and regular physical activity.
  • Evolving Research: Ongoing studies continue to explore the long-term cardiovascular and metabolic benefits of liraglutide, as well as its potential applications beyond diabetes and obesity, including in non-alcoholic fatty liver disease (NAFLD).


Description

Contrave is an FDA-approved prescription medication used to help manage weight. It is indicated for adults with obesity (a body mass index [BMI] of ≥30) or overweight adults (BMI of ≥27) who also have at least one weight-related condition such as hypertension, type 2 diabetes, or high cholesterol. Unlike semaglutide—which is a GLP-1 agonist used for type 2 diabetes and later for weight management under the name Wegovy—Contrave uses a combination of two active ingredients: naltrexone and bupropion. The two components work together to address different aspects of appetite and reward pathways in the brain, helping to reduce food cravings and control appetite when used in combination with diet and exercise.

Also Known As

  • Generic Names: Naltrexone HCl / Bupropion HCl
  • Brand Name: Contrave

Unlike semaglutide’s alternate identity as Wegovy when used for weight loss, Contrave remains known by its brand name or its component names.

Avoid When

Contrave should not be used in the following circumstances:

  • History of Seizures: Because bupropion can lower the seizure threshold.
  • Eating Disorders: Avoid in individuals with anorexia or bulimia nervosa.
  • Uncontrolled Hypertension: As the medication may raise blood pressure.
  • Current Opioid Use or Addiction: Naltrexone is contraindicated with active opioid therapy.
  • Pregnancy or Breastfeeding: It is not recommended in those who are pregnant, trying to conceive, or breastfeeding due to potential risks.
  • Recent MAOI Use: Because of the risk of dangerous drug interactions.

Side Effects

The most commonly reported side effects with Contrave include:

  • Nausea: Occurs for many patients (studies often cite nausea as a leading complaint).
  • Constipation: Gastrointestinal discomfort is relatively common.
  • Headache: Often reported during the initial phase of treatment.
  • Dizziness and Vomiting: Also noted, though less frequent than nausea.

While percentages differ from one study to another, nausea and headache are among the most common across clinical trials. (For comparison, semaglutide’s reported side effects in its trials also include nausea and gastrointestinal symptoms, but the incidence rates are specific to each drug’s profile).

How It Works in My Body

Contrave works primarily on the central nervous system. Its two components have distinct yet complementary actions:

  • Bupropion: An atypical antidepressant that not only helps improve mood and energy but also functions as an appetite suppressant. It acts on the hypothalamus to dampen hunger and may affect the reward centers in the brain.
  • Naltrexone: Originally used to manage addiction, it helps curb food cravings by modulating the brain’s reward pathways. It works in concert with bupropion to potentially reduce the urge to eat and to blunt the reinforcement one might receive from consuming high-calorie foods.

Together, these actions help patients adhere to dietary changes while reducing the impulses that can lead to overeating.

Research Results

Clinical studies have indicated that when combined with lifestyle modifications—specifically diet and exercise—Contrave can lead to modest but significant weight loss in many patients. A common finding across trials is that patients on Contrave tend to lose more weight than those on placebo, although individual results can vary. Research continues to evaluate its long‐term benefits and overall impact on weight‐related health conditions. Patients are advised to work closely with their healthcare providers to monitor progress and manage any side effects during treatment.

Additional Information You Might Find Interesting

  • Mechanism Nuances: Although the exact neurochemical effects by which Contrave induces weight loss are not fully understood, its design to target hypothalamic appetite centers and reward circuits distinguishes it from other weight-loss medications like semaglutide.
  • Lifestyle Emphasis: Like most weight loss medications, Contrave is most effective when used as part of a comprehensive weight management program that includes a balanced diet and regular physical activity.
  • Monitoring: Because of potential side effects and contraindications, routine follow-ups, including blood pressure checks and mental health assessments, are integral to safe and effective use of Contrave.


Description

Metformin is a well-established medication that falls under the biguanide class and has been the first-line treatment for type 2 diabetes since its FDA approval in 1994. Although it is primarily indicated for glycemic control in individuals with type 2 diabetes, many patients experience modest weight loss while on the medication. This weight reduction is not the primary intent of metformin; rather, it tends to occur as a secondary benefit, potentially related to appetite suppression and gastrointestinal side effects.

Also Known As

  • Generic Name: Metformin
  • Brand Names
    • Glucophage (most common)
    • Glucophage XR (extended release), among others

In clinical discussions and studies on metabolic benefits, metformin is referred to by its generic name or known under the various brand associations it carries.

Avoid When

Metformin is generally safe for most patients with type 2 diabetes; however, there are certain situations in which its use is not recommended:

  • Renal Impairment: Patients with significant kidney dysfunction or a reduced estimated glomerular filtration rate (eGFR) should avoid metformin.
  • Liver Disease: Severe liver impairment may predispose patients to lactic acidosis.
  • Acute Conditions: Use caution or avoid during situations of acute alcohol intoxication or conditions that predispose to hypoxia (e.g., severe infections or cardiovascular events).
  • Contrast Studies: It should be held around the time of radiologic studies using intravenous contrast to reduce the risk of lactic acidosis.

Always consult with your healthcare provider before starting or stopping metformin, especially if there are any pre-existing conditions that might heighten the risk of adverse effects.

Side Effects

While metformin is largely well tolerated, its most common side effects include:

  • Gastrointestinal Distress: This may involve nausea, vomiting, diarrhea, and abdominal discomfort.
  • Appetite Reduction: While not intentional, the decrease in appetite may contribute to weight loss.
  • Rare but Serious: Lactic acidosis is an infrequent yet life-threatening side effect that can occur, particularly in patients with contraindicated conditions.

These side effects explain both its therapeutic impact on blood sugar and its ancillary effect on weight, as reduced appetite and GI upset may lead to lower caloric intake.

How It Works in My Body

Metformin primarily functions by lowering hepatic glucose production (gluconeogenesis) while simultaneously increasing insulin sensitivity in peripheral tissues. The drug may also influence weight through several pathways:

  • Appetite Regulation: Some studies suggest that metformin may interfere with hunger signaling in the brain, possibly via alterations in gut hormones or the gut microbiome.
  • Energy Utilization: By improving insulin sensitivity, the body may use energy more efficiently, thus inhibiting overeating and reducing fat accumulation.
  • Delayed Gastric Emptying: In some cases, its effect on gastrointestinal motility can result in prolonged satiety.

These combined effects help regulate blood sugar levels, and in patients predisposed to weight gain, metformin often results in modest weight loss as a secondary benefit.

Research Results

Clinical research on metformin has consistently shown that while it is effective for maintaining glycemic control in type 2 diabetes, it can also contribute to weight loss. For example:

  • Sustained Weight Reduction: Studies tracking patients over many years have noted that individuals who lose weight while on metformin often maintain some degree of weight loss over the long term, provided the medication is continued alongside lifestyle modifications.
  • Modest but Significant: The weight loss observed is usually modest compared to dedicated weight loss medications, but it is significant when considering the primary metabolic target and long-term cardiovascular benefits.
  • Appetite and Microbiome Changes: There is ongoing research into how metformin’s impact on gut hormones and the microbiome might play a role in appetite suppression and overall energy intake reduction.

Additional Insights

  • Not a Stand-Alone Weight Loss Drug: Although metformin can lead to weight loss, it is prescribed primarily for managing blood sugar. Its weight-loss effects should be viewed as an added benefit rather than a primary treatment modality.
  • Lifestyle Integration: The best outcomes are observed when metformin is combined with a balanced diet and regular physical activity, reinforcing the importance of holistic lifestyle modifications.
  • Ongoing Research: Scientists continue to investigate the precise mechanisms behind metformin’s impact on weight and whether these properties might be optimized or complemented by adjunct therapies in the future.


Description

Orlistat is a lipase inhibitor designed to aid weight loss. It works by blocking the absorption of dietary fats in the gastrointestinal tract, so that approximately 25%–30% of ingested fat is not absorbed and is subsequently excreted in the stool. Orlistat is typically prescribed for overweight or obese adults who need help managing their weight and is most effective when combined with a reduced-calorie, low-fat diet and increased physical activity.

Also Known As

  • Generic Name: Orlistat
  • Brand Names:
    • Xenical: The prescription-strength formulation.
    • Alli: The over-the-counter version available in a lower dose.

Both formulations share the same active ingredient, but the dosing and available strength differ, with Xenical prescribed for individuals with a higher body mass index or specific weight-loss needs, and Alli being a consumer-accessible option for milder cases of overweight.

Avoid When

Orlistat should be used cautiously or avoided under certain circumstances:

  • Digestive Disorders: Individuals with chronic malabsorption syndrome or cholestasis (problems with bile flow) should avoid this medication since orlistat further reduces fat absorption.
  • Pregnancy and Breastfeeding: Weight loss is not recommended during pregnancy, and the safety during breastfeeding is not established.
  • Severe Liver Disease: Because of potential alterations in fat metabolism, orlistat should be used cautiously.
  • High-Fat Meals: Although not a contraindication per se, consuming high-fat meals while on orlistat can increase the likelihood of gastrointestinal side effects such as oily spotting or flatus with discharge.

Side Effects

The most commonly reported side effects of orlistat are gastrointestinal in nature, stemming from its mechanism of action:

  • Fatty/Stool Discharge: Unabsorbed fats may lead to oiliness or the appearance of oily spotting.
  • Loose Stools or Diarrhea: Often accompanied by an urgent need to defecate, especially after high-fat meals.
  • Abdominal Pain or Discomfort: Cramping or bloating can occur as your body excretes undigested fat.
  • Reduced Absorption of Fat-Soluble Vitamins: Long-term use may decrease the absorption of vitamins A, D, E, and K; thus, taking a multivitamin at a different time of day is generally advised.

These side effects are usually dose-dependent and can be minimized by adhering to a lower-fat diet throughout treatment.

How It Works in My Body

Orlistat works locally in the gastrointestinal tract by inhibiting pancreatic and gastric lipases—enzymes responsible for breaking down dietary fats. Without sufficient enzymatic action, fats are not completely hydrolyzed into absorbable free fatty acids and monoglycerides. As a consequence:

  • Decreased Fat Absorption: Approximately 25%–30% of ingested fat is excreted rather than absorbed, leading to a reduction in overall caloric intake.
  • Weight Loss: Over time, with consistent use and dietary adherence, the reduction in fat absorption contributes to modest—but clinically significant—weight loss.
  • Nutrient Considerations: Because some fat-soluble vitamins rely on fat absorption, supplemental vitamins may be necessary to prevent deficiencies.

This gastrointestinal mechanism makes orlistat distinct from medications that act centrally and it works best as part of a complete lifestyle modification program.

Research Results

Clinical studies have validated orlistat’s role in weight management:

  • Modest Weight Reduction: Research demonstrates that individuals using orlistat, in conjunction with dietary modifications, can achieve an average weight loss in the range of 5%–10% of their starting body weight over the course of one year.
  • Improved Metabolic Markers: Beyond weight loss, orlistat has been associated with improvements in blood lipid profiles and reductions in blood pressure, owing partly to the reduced absorption of fat.
  • Long-Term Efficacy: Longitudinal studies indicate that sustained lifestyle changes paired with orlistat use may help maintain weight loss, although adherence to diet and exercise remains a critical component.

These findings support the use of orlistat as a complementary tool in combating obesity and its related metabolic complications.

Additional Insights

  • Dietary Integration: The success of orlistat relies heavily on adherence to a low-fat diet. Educating patients about proper dietary choices is crucial to minimize gastrointestinal side effects.
  • Supplementation Needs: To counteract the decreased absorption of fat-soluble vitamins, a daily multivitamin taken at least 2 hours apart from orlistat is generally recommended.
  • Patient Selection and Monitoring: Orlistat is most effective in motivated patients who are also engaged in a comprehensive weight management program that includes nutritional counseling, physical activity, and regular follow-up with healthcare providers.


Description

Phentermine is a prescription medication approved by the FDA for short-term weight management. Typically used for up to 12 weeks, phentermine is intended for overweight or obese individuals, often in the context of a reduced-calorie diet and increased physical activity. It functions as an appetite suppressant that stimulates the central nervous system, leading to decreased hunger and reduced caloric intake. Phentermine’s chemical structure is similar to that of amphetamines, which contributes to its stimulant properties and controlled substance classification.

Also Known As

  • Generic Name: Phentermine
  • Brand Names:
    • Adipex-P
    • Lomaira
    • Suprenza

In many clinical settings and research discussions, phentermine is referenced by its generic name or one of its established brand names.

Avoid When

Phentermine should be avoided or used with caution in certain populations:

  • Pregnancy and Breastfeeding: Phentermine is contraindicated in pregnant or nursing women, as weight-loss during pregnancy can adversely affect fetal development.
  • Cardiovascular Conditions: It should not be used by individuals with a history of heart disease, uncontrolled high blood pressure, coronary artery disease, or congestive heart failure due to its stimulatory effects on heart rate and blood pressure.
  • Glaucoma: Individuals with glaucoma should avoid phentermine owing to increased intraocular pressure.
  • Hyperthyroidism: Patients with an overactive thyroid may experience amplified adverse effects.
  • Drug Abuse History: Given its chemical similarity to amphetamines, it is contraindicated in individuals with a history of drug abuse.
  • MAOI Use: Its use in combination with, or shortly after, monoamine oxidase inhibitors (MAOIs) is strictly avoided due to the risk of dangerous drug interactions.

Side Effects

Common side effects associated with phentermine include:

  • Central Nervous System Effects: Restlessness, insomnia, and anxiety are frequently reported.
  • Cardiovascular Effects: Increases in heart rate and blood pressure are possible, and some patients may experience palpitations.
  • Dry Mouth: A common complaint that may contribute to dehydration if fluid intake is inadequate.
  • Gastrointestinal Discomfort: Nausea and constipation can occur in some individuals.
  • Rare but Serious Effects: There have been reports of primary pulmonary hypertension and heart valve issues, which underline the importance of careful patient selection and monitoring.

How It Works in My Body

Phentermine primarily works as a centrally acting stimulant:

  • Appetite Suppression: It increases the levels of key neurotransmitters such as norepinephrine (and likely dopamine and serotonin), leading to reduced hunger signals in the brain.
  • Energy Expenditure: By stimulating certain brain pathways, it may marginally boost energy levels, which can contribute to increased physical activity.
  • Controlled Substance Nature: Because of its structural similarity to amphetamines, it has the potential for abuse or dependence, necessitating strict adherence to prescribed dosing and duration of therapy.

These combined effects help reduce caloric intake and facilitate weight loss when used alongside lifestyle modifications.

Research Results

Clinical studies evaluating phentermine have consistently shown that when combined with a reduced-calorie diet and increased physical activity, it can lead to significant short-term weight loss in overweight and obese individuals. Its efficacy in reducing appetite and accelerating weight loss is well documented; however, its use is generally limited by concerns over cardiovascular side effects and potential dependency. Consequently, phentermine is recommended for a limited duration (typically 12 weeks or less), and patients are closely monitored throughout treatment.

Additional Insights

  • Short-Term Use Emphasis: Phentermine is designed as a short-term adjunct to lifestyle changes; it is not intended as a long-term weight-loss solution.
  • Synergy with Lifestyle Modifications: The best outcomes are achieved when phentermine is integrated into a broader weight management program that includes dietary counseling and regular exercise.


*DEA CONTROLLED MEDICATION: PRESCRIBING RESTRICTIONS APPLY*


Description

Qsymia is a prescription weight-management medication approved for chronic weight loss in adults. It is a fixed-dose combination of two active ingredients: phentermine, a sympathomimetic amine that acts as an appetite suppressant, and topiramate extended release, an anticonvulsant that helps enhance satiety. Qsymia is indicated for adults with an initial body mass index (BMI) of 30 kg/m² or greater (obesity) or those with a BMI of 27 kg/m² or greater (overweight) who also have at least one weight-related medical condition (such as hypertension, type 2 diabetes, or high cholesterol). The medication is taken once daily and is intended to be used in conjunction with a reduced-calorie diet and increased physical activity.

Also Known As

  • Generic Components:
    • Phentermine: Primarily an appetite suppressant.
    • Topiramate (extended release): An anticonvulsant that also enhances feelings of fullness.
  • Brand Name: Qsymia
  • Other References: Qsymia is sometimes informally referred to by its component names in discussions about combination therapy for weight loss.

Both active ingredients contribute synergistically to reduce hunger and caloric intake while supporting sustained weight loss when combined with lifestyle changes.

Avoid When

Certain conditions or situations warrant caution or complete avoidance of Qsymia:

  • Pregnancy: Qsymia is contraindicated during pregnancy due to the risk of birth defects, most notably cleft lip and cleft palate. Women who can become pregnant are required to use effective contraception and undergo regular pregnancy testing.
  • Glaucoma or Thyroid Problems: Patients with certain eye or thyroid conditions (including hyperthyroidism) should avoid Qsymia.
  • MAOI Use: Concurrent or recent use of monoamine oxidase inhibitors (MAOIs) is contraindicated.
  • Allergies: Individuals allergic to topiramate, sympathomimetic amines such as phentermine, or any of the drug’s ingredients should not take Qsymia.
  • Other Medical Considerations: Patients with cardiovascular issues or those with a history of substance abuse may need careful evaluation before initiating treatment.

Side Effects

Qsymia’s side effect profile is primarily linked to its individual components:

  • Common Gastrointestinal Effects: These can include dry mouth, constipation, or diarrhea.
  • Central Nervous System Effects: Patients may experience dizziness, altered taste (especially a metallic taste), or insomnia.
  • Increased Heart Rate: An elevation in resting heart rate may occur, warranting monitoring by a healthcare provider.
  • Potential Cognitive Impairment: Some users report difficulty with attention or memory, which may be related to topiramate.
  • Teratogenicity: The risk of birth defects is significant if taken during pregnancy.

The side effects are generally dose-dependent and, for many patients, tend to diminish over the course of treatment. Adherence to the recommended dosing schedule—usually involving a slow titration phase—can help minimize adverse reactions.

How It Works in My Body

Qsymia exerts its weight-loss effects through a dual mechanism:

  • Phentermine Component: Acts centrally as a sympathomimetic amine that reduces appetite by stimulating the release of norepinephrine in the brain, thereby helping lower caloric intake.
  • Topiramate Component: Although not completely understood, topiramate is thought to promote satiety, reduce food cravings, and possibly alter taste sensations, further reducing overall food consumption.

Together, these actions help sustain a reduced appetite and support behavioral changes that lead to significant weight loss over time when combined with an appropriate diet and exercise program.

Research Results

Clinical trials have demonstrated Qsymia’s effectiveness in weight management:

  • Significant Weight Loss Findings: In clinical studies spanning 56 weeks, patients on Qsymia—particularly at higher doses (approximately 15 mg phentermine/92 mg topiramate)—achieved an average weight loss of around 10%–11% of their initial body weight.
  • Metabolic Improvements: Along with weight reduction, many studies have reported improvements in waist circumference, blood pressure, and other metabolic markers.
  • Long-Term Benefits: The trials also showed that when used as part of a comprehensive weight management program, Qsymia leads to more meaningful and sustained weight loss compared with lifestyle modifications alone.

Such outcomes have provided the foundation for Qsymia’s approval and its use as a pharmacological adjunct to diet and exercise in obesity management.

Additional Insights

  • Dosing and Titration: Qsymia is available in several dosing strengths, and a gradual titration schedule is recommended to reduce the risk of side effects while optimizing weight-loss outcomes.
  • Comprehensive Approach: Like most weight-loss therapies, Qsymia works best when patients adhere to a lifestyle program that includes a balanced, reduced-calorie diet and regular physical activity.
  • Patient Monitoring: Regular follow-up is essential, not only to track weight loss but also to monitor for changes in heart rate and any potential cognitive or mood-related side effects.


*DEA CONTROLLED MEDICATION: PRESCRIBING RESTRICTIONS APPLY*


Description

Topamax is an anticonvulsant medication that is FDA approved for the treatment of seizures and for migraine prevention. Although it is not specifically approved for weight loss, its use off-label for this purpose is common due to the consistent observation that patients tend to lose weight during therapy. In fact, when combined with phentermine (a stimulant appetite suppressant) in the FDA-approved formulation known as Qsymia, topiramate’s weight-reducing properties are leveraged for treating obesity.

Also Known As

  • Generic Name: Topiramate
  • Brand Name: Topamax for its original indications
  • Combination Product: Qsymia (phentermine/topiramate ER) is the only FDA-approved drug that combines topiramate with phentermine specifically for chronic weight management.

Even when prescribed on its own for weight loss, topiramate is still referred to by its generic name, particularly in off-label settings.

Avoid When

Topiramate should be used with caution or avoided in certain situations:

  • History of Glaucoma: It can increase pressure in the eyes.
  • Metabolic Acidosis or Significant Acid–Base Imbalances: Because the drug may alter acid–base balance, caution is needed.
  • Kidney Problems or History of Kidney Stones: Topiramate can predispose to these conditions.
  • Pregnancy: The medication has teratogenic potential, so it should not be used during pregnancy or when planning to conceive.
  • Cognitive or Sensory Impairments: Patients with a history of difficulties related to cognitive slowing or paresthesia might experience a worsening of these symptoms.

Side Effects

The side effects associated with topiramate are well-documented, especially from its use in epilepsy and migraine prevention, and include:

  • Abnormal Sensations: Many users report tingling, numbness, or unusual skin sensations.
  • Altered Taste: Changes in taste perception (dysgeusia) are common, often leading to reduced appetite.
  • Cognitive Effects: Some individuals experience slowed thinking or difficulty with concentration and memory.
  • Gastrointestinal Symptoms: Mild nausea or gastrointestinal discomfort may occur.

For weight loss purposes, the appetite-suppressing effects that contribute to these side effects are also the factors believed to drive reduced caloric intake.

How It Works in My Body

The exact mechanism by which topiramate induces weight loss is not fully understood, but several potential effects are recognized:

  • Appetite Suppression: Topiramate may reduce hunger and cravings, leading to lower overall calorie intake.
  • Increased Satiety: Some evidence suggests the drug helps people feel full sooner during meals, thus reducing the amount eaten at each meal.
  • Metabolic Effects: While not its primary function, topiramate might influence energy balance and fat metabolism, contributing to its weight-reducing properties.

These effects combine to yield the modest yet meaningful reductions in body weight often observed during treatment, especially when paired with lifestyle modifications.

Research Results

Multiple clinical studies have examined topiramate’s impact on body weight:

  • Efficacy in Weight Loss: Studies show that patients taking topiramate off-label for weight loss can achieve an average loss of around 5%–7% of their body weight after 24 weeks.
  • Dose Dependency: Research suggests that higher doses and sustained use might result in more pronounced weight loss.
  • Combination Therapy: When used in combination with phentermine as Qsymia, the weight loss outcomes tend to be even more significant, indicating a synergistic effect of the two medications.

Such research underpins the rationale for using topiramate as a weight-loss tool, either alone (off-label) or as part of a combined therapy.

Additional Insights

  • Off-Label but Common: Though not FDA approved for weight loss by itself, topiramate’s off-label use is widespread among healthcare providers due to its beneficial side effect profile regarding weight reduction.
  • Lifestyle Integration: As with any medication for weight management, the best results occur when topiramate is combined with healthy dietary changes and regular physical activity.
  • Further Research: Ongoing studies continue to explore the optimal dosing, long-term efficacy, and safety profile of topiramate for weight management. Whether used DIY or as part of a combination product, its potential in improving metabolic outcomes remains a subject of active investigation.


Description

Naltrexone is a medication primarily approved for the treatment of opioid and alcohol use disorders. It functions as an opioid receptor antagonist, meaning it binds to opioid receptors in the brain without activating them, thereby blocking the euphoric and reinforcing effects of opioids. This same property has led researchers to explore naltrexone as a tool for weight loss—especially when combined with other medications, such as bupropion. In this dual-therapy approach (marketed as Contrave), naltrexone contributes to reducing cravings and curbing overeating by modulating the reward centers involved in eating behavior.

Also Known As

  • Generic Name: Naltrexone
  • Brand Names:
    • For addiction: Naltrexone (used under its generic name or brands like ReVia for alcohol dependence)
    • As part of combination therapy for weight loss: Contrave (naltrexone combined with bupropion)

When discussed in obesity management, naltrexone is typically referenced as a component in combination products rather than as a single agent.

Avoid When

Naltrexone should not be used or should be used with extreme caution in certain populations:

  • Active Opioid Use or Dependence: Naltrexone will block the effects of opioids, which can precipitate withdrawal in individuals dependent on opioids.
  • Acute Opioid Withdrawal: It is generally avoided until the withdrawal process is complete.
  • Liver Disease or Hepatic Dysfunction: Since the medication is metabolized in the liver, significant liver impairment can increase the risk of adverse effects.
  • Pregnancy and Breastfeeding: Though not an absolute contraindication in all cases, caution is advised when considering naltrexone for women who are pregnant, planning to conceive, or currently breastfeeding.

Side Effects

The side effects associated with naltrexone, when used for addiction management, can be similar when it is applied in weight loss strategies:

  • Gastrointestinal Issues: Nausea is one of the more common side effects.
  • Headache: Some users may experience headaches during the initial treatment phase.
  • Dizziness: A subset of patients report feeling lightheaded or dizzy.
  • Fatigue: Some individuals experience tiredness, which may relate to its effects on the central nervous system.

When used as part of combination therapy (such as in Contrave), the overall side effect profile may also include those related to the companion medication (bupropion), which further aids in appetite suppression and mood regulation.

How It Works in My Body

Naltrexone’s mechanism is centered on its action as an opioid receptor antagonist:

  • Blocking Opioid Receptors: By occupying the mu, delta, and kappa opioid receptors without activating them, naltrexone diminishes the brain’s reward response associated with both opioid use and, interestingly, food consumption.
  • Reduction in Cravings: In the context of weight loss, the decreased reward from food—particularly highly palatable, calorie-dense foods—can help reduce overeating.
  • Modulation of Neurotransmission: This blockage can subtly influence other neurotransmitter systems, such as those involving dopamine, which plays a role in the reinforcement of eating behaviors.

This mechanism provides a rationale for its use in weight loss—especially when the goal is to diminish the incentive to consume excess calories and manage binge eating patte.

Research Results

Clinical studies have shed light on the role of naltrexone in weight management:

  • Combination With Bupropion: Research has consistently demonstrated that when naltrexone is combined with bupropion (forming Contrave), patients experience statistically significant weight loss compared to placebo. Studies over 52 to 56 weeks have shown meaningful reductions in body weight for patients struggling with obesity or who are overweight.
  • Appetite and Reward Modulation: The underlying principle observed is that naltrexone helps regulate the reward systems that influence both substance use and overeating. This effect, when paired with bupropion’s action on mood and appetite, creates a synergistic effect beneficial for weight loss.
  • Limited Efficacy When Used Alone: It’s important to note that naltrexone’s weight loss effects are generally modest when used as a single agent, which is why it is mostly implemented as part of combination therapy for obesity management.

These studies help position naltrexone not as a stand-alone weight loss pill but as an adjunctive treatment in a broader weight management plan that includes lifestyle and dietary interventions.

Additional Insights

  • Holistic Approach: The best outcomes with naltrexone-based treatments occur when integrated into comprehensive plans that include diet, exercise, and behavioral therapy.
  • Patient Selection: Not every patient is an ideal candidate for naltrexone, particularly those needing ongoing opioid treatment. A thorough clinical assessment is fundamental to ensure safety and fast-track benefits.
  • Emerging Research: As the obesity epidemic continues, ongoing research is focused on optimizing the dosing, maximizing combination strategies, and understanding the neurohormonal underpinnings of weight loss associated with naltrexone therapy.


Description

Bupropion is an atypical antidepressant that was originally developed to treat major depressive disorder and seasonal affective disorder. It is also used as a smoking cessation aid under the brand name Zyban. One distinctive feature of bupropion is that, unlike many other antidepressants that are associated with weight gain, it is more commonly linked to weight loss or at least weight neutrality. In many clinical settings, people treated with bupropion experience reduced appetite and modest weight loss, a side effect that has contributed to its consideration in weight management, particularly when used as a component in combination therapies like Contrave (with naltrexone).

Also Known As

  • Generic Name: Bupropion
  • Brand Names:
    • Wellbutrin: Used primarily for the treatment of depression (immediate-release, sustained-release, or extended-release formulations)
    • Zyban: Indicated for smoking cessation
    • Contrave (in combination with naltrexone): Approved for weight management
    • Other names include Aplenzin and Forfivo (extended-release versions)

Each formulation has its approved indication, yet they all rely on bupropion’s unique mechanism of modulating dopamine and norepinephrine levels, which may also contribute to appetite suppression and energy regulation.

Avoid When

Bupropion should be used with caution or avoided altogether in certain situations:

  • Seizure Disorders: Bupropion is known to lower the seizure threshold, so it is contraindicated in patients with a history of seizures.
  • Eating Disorders: A history of anorexia or bulimia is a contraindication because of the increased risk of seizures.
  • Abrupt Discontinuation of Alcohol or Sedatives: Since withdrawal from these substances may lower seizure thresholds, caution is necessary.
  • Concurrent Use of Monoamine Oxidase Inhibitors (MAOIs): These can interact dangerously, so an appropriate washout period should be observed.
  • Pregnancy and Breastfeeding: Although bupropion is sometimes used during pregnancy, its benefits and risks must be carefully evaluated by a healthcare provider.

Side Effects

The common side effects associated with bupropion include:

  • Gastrointestinal Distress: Such as nausea or dry mouth.
  • Insomnia: Difficulty sleeping may occur in some patients.
  • Headache: A frequent complaint, particularly during the early phase of treatment.
  • Appetite Suppression and Weight Loss: Many studies have observed that a notable percentage of patients experience weight loss, which appears to be dose related and more pronounced in individuals with a higher baseline BMI.
  • Increased Anxiety or Agitation: Some patients report feeling more anxious or agitated.

Because of its effect on neurotransmitters that regulate appetite and reward, the weight loss seen with bupropion is considered an ancillary benefit in many cases, although it is not marketed or prescribed solely for weight management.

How It Works in My Body

Bupropion exerts its effects by influencing key neurotransmitters:

  • Dopamine and Norepinephrine Reuptake Inhibition: By blocking the reuptake of these neurotransmitters, bupropion enhances their availability in the brain. This action is linked not only to its antidepressant effects but also to improved mood and increased energy.
  • Appetite Regulation: The changes in dopamine and norepinephrine may help reduce cravings, enhance motivation, and suppress appetite. Patients taking bupropion sometimes report decreased hunger and food intake, which can contribute to weight loss.
  • Impact on Reward Pathways: The modulation of the mesolimbic reward system helps reduce the reinforcing effects of food, particularly highly palatable, calorie-dense foods, thereby aiding in controlling overeating.

These combined actions underlie bupropion’s use in treating depression and aiding smoking cessation as well as its observed influence on weight when used in appropriate populations.

Research Results

Clinical investigations have highlighted bupropion’s potential for weight loss:

  • Clinical Trials: Several studies comparing bupropion to placebo have shown that individuals on bupropion are more likely to experience a modest weight reduction—often defined as losing at least 5% of body weight over several weeks or months.
  • Comparison with Other Antidepressants: Data indicate that bupropion-treated patients tend to have a more favorable weight profile compared to other antidepressants which are often linked to weight gain.
  • Combination Therapies: When combined with naltrexone (as in Contrave), the dual mechanism—affecting both reward pathways and energy regulation—can yield a synergistic effect on reducing caloric intake and enhancing weight loss outcomes.

While weight loss is viewed as a positive additional effect, bupropion is prescribed primarily for its mood-regulating properties and smoking cessation benefits, and its use in weight management is typically as part of a broader treatment plan.

Additional Insights

  • Not Primarily a Weight-Loss Drug: Although weight loss is a beneficial side effect for many patients, bupropion is not FDA-approved solely for the treatment of obesity. It should be prescribed based on its primary indications.
  • Lifestyle Considerations: For optimal outcomes, any weight-related benefits are best realized when bupropion is combined with a balanced diet, regular exercise, and behavioral support.
  • Comparative Effectiveness: For patients interested in weight management, discussing the relative merits of bupropion-containing therapies versus other weight-loss medications with a healthcare provider can help determine an individualized plan that accounts for overall health needs.


Schedule a Consult Today

Let's Get Started

SCHEDULE MY APPOINTMENT

  • VITALITY WELLNESS
  • Vitamin Infusions
  • Appointments
  • Women's Health
  • Men's Health
  • Weight Loss
  • Lab Screening
  • Hair Regrowth
  • Medical Forms
  • Zepbound for Sleep Apnea
  • Skin Care
  • Tampa Florida Telehealth
  • Ortonville Mi Clinic
  • Las Vegas NV Telehealth
  • Phoenix AZ Telehealth
  • CONTACT
  • Patient Resources
  • PRIVACY
  • ICARENP BLOG

Copyright © 2024 ICARENP- All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept